Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patients
S Harricharan, K Biederman, AM Bombassaro… - Current …, 2018 - mdpi.com
Background: A twice-weekly galactomannan (GM) screening protocol was implemented in
high-risk hematology inpatients. Study objectives were to determine adherence to the …
high-risk hematology inpatients. Study objectives were to determine adherence to the …
Presence of HSP90 Gene in Amphotericin B Resistant Aspergillus Species Isolated from Iranian Immunocompromised Patients
N Ghods, M Falahati, M Roudbary… - Infection …, 2017 - iem.modares.ac.ir
Background: Aspergillosis is an opportunistic infection caused by Aspergillus spp in
immunocompromised patients. The role of HSP90 in Aspergillus drug resistance is still …
immunocompromised patients. The role of HSP90 in Aspergillus drug resistance is still …
The multiple faces of the human immune system: Modern life causes low-grade inflammation and thereby provokes conflict between the selfish immune system and …
L Pruimboom - 2017 - research.rug.nl
This thesis describes the multiple ways by which the human immune system can react upon
direct and indirect challenges, such as infection and wounds on the one hand, and chronic …
direct and indirect challenges, such as infection and wounds on the one hand, and chronic …
[PDF][PDF] Antifungal drugs for coccidioidomycosis
JH Rex - 2022 - f2g.com
1. IA= Invasive Aspergillosis 2. Wingard, JR, et al.(2008)." Changes in causes of death over
time after treatment for invasive aspergillosis." Cancer 112 (10): 2309-2312. 3. Segal BH et …
time after treatment for invasive aspergillosis." Cancer 112 (10): 2309-2312. 3. Segal BH et …
Leitliniengerechte Therapie der invasiven Aspergillose
M Karthaus - Mycoses, 2010 - Wiley Online Library
Zusammenfassung Invasive Pilzinfektionen durch Aspergillus spp. treten überwiegend bei
gestörter Immunabwehr auf. Sie sind auch heute noch mit einer hohen …
gestörter Immunabwehr auf. Sie sind auch heute noch mit einer hohen …
[PDF][PDF] Antifungal Drugs to Address Unmet Medical Need
JH Rex - f2g.com
1. IA= Invasive Aspergillosis 2. Wingard, JR, et al.(2008)." Changes in causes of death over
time after treatment for invasive aspergillosis." Cancer 112 (10): 2309-2312. 3. Segal BH et …
time after treatment for invasive aspergillosis." Cancer 112 (10): 2309-2312. 3. Segal BH et …
[PDF][PDF] IDENTIFICAÇÃO MOLECULAR DE ESPÉCIES
MIBS Elói - run.unl.pt
As aspergiloses são cada vez mais diagnosticadas em todo o mundo, nas suas diversas
formas de apresentação, tanto pelo aumento da população susceptível como pela melhoria …
formas de apresentação, tanto pelo aumento da população susceptível como pela melhoria …
Are respiratory complications more likely in patients with pulmonary aspergillosis treated with echinocandins in the setting of neutrophil influx?
DP Kontoyiannis - Virulence, 2014 - Taylor & Francis
The recently completed phase III NHLBI-sponsored randomized controlled study (RING trial,
NCT00627393) hopefully will address some of the controversies of the impact of GTX in …
NCT00627393) hopefully will address some of the controversies of the impact of GTX in …
[PDF][PDF] Corresponding Author: John R. Wingard
MW Sugrue - 2021 - academia.edu
Using more stringent consensus definitions for Invasive Aspergillosis, more than 20% of
cases in hematopoietic cell transplant and hematologic malignancies patients that met …
cases in hematopoietic cell transplant and hematologic malignancies patients that met …
[PDF][PDF] Voriconazole resistance and mortality in invasive aspergillosis: A multicenter retrospective cohort study
HA Hoven10, WJG Melchers, AF de Haan - pure.eur.nl
Methods A 5-year retrospective cohort study (2011-2015) was conducted to compare
mortality in patients with voriconazole-susceptible and voriconazole-resistant IA. A …
mortality in patients with voriconazole-susceptible and voriconazole-resistant IA. A …